▶ 調査レポート

肝臓ヒト化マウスモデルの世界市場

• 英文タイトル:Global Market Study on Humanized Liver Mice Model: Application in New Drug Development for Liver Cancer to Support Growing Demand for In-vivo Toxicity Testing
• レポートコード:C-PMR-JN046
• 出版社/出版日:Persistence Market Research / 2018年11月
• レポート形態:英文、PDF、198ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:ライフサイエンス・トランスフォーメーションヘルス
• 販売価格(消費税別)
  Individual(1名、印刷不可)¥529,200 (USD4,900)▷ お問い合わせ
  Multi User(5名)¥820,800 (USD7,600)▷ お問い合わせ
  Corporate User¥1,144,800 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要

A recent market study published by the company – “Humanized Liver Mice Model Market Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026” consists a comprehensive assessment of the most important market dynamics. On conducting a comprehensive research on the historic as well as current growth parameters of the Humanized Liver Mice Model market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that are likely to have a high impact on the development of the Humanized Liver Mice Model market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in the Humanized Liver Mice Model market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Humanized Liver Mice Model market in the most comprehensive manner for the better understanding of readers.
Chapter 1 – Executive Summary

The report commences with the executive summary of the Humanized Liver Mice Model market report, which includes the summary of key findings and key statistics of the Humanized Liver Mice Model market. It also includes the market value (US$ million) estimates of the leading segments of the Humanized Liver Mice Model market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and the definition of the Humanized Liver Mice Model market in this chapter, which helps them understand the basic information about the Humanized Liver Mice Model market dynamics, opportunity analysis, list of key distributors & suppliers, list of key market participants, epidemiology study, and patent assessment.

Chapter 3 – North America Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026

This chapter includes a detailed analysis of the growth of the North America Humanized Liver Mice Model market along with a country-wise assessment that includes the U.S. and Canada. Readers can also find market growth and market attractiveness analysis based on model, application, end user and country of the Humanized Liver Mice Model in the North American region.

Chapter 4 – Latin America Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026

Readers can find detailed information about the growth of the Latin America Humanized Liver Mice Model market. This chapter also includes the growth prospects of the Humanized Liver Mice Model market in leading LATAM countries such as Brazil, Mexico and the rest of the Latin America region.

Chapter 5 – Europe Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026

Important growth prospects of the Humanized Liver Mice Model market based on its model, applications and end user in several European countries, such as U.K., Germany, France, Italy, Spain, Russia and rest of Europe, are included in this chapter.

Chapter 6 – Asia Pacific Excluding China (APEC) Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026

India, Japan, ASEAN, Australia and New Zealand are the leading countries in the APEC region, which are the prime subjects of assessment to obtain the growth prospects of the APEC Humanized Liver Mice Model market in this chapter. Readers can find detailed information about the growth parameters of the APAC Humanized Liver Mice Model market during the period 2018-2026.

Chapter 7 – China Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026

Readers can find detailed information about the growth parameters of the China Humanized Liver Mice Model market during the period 2018-2026 in this chapter.

Chapter 8 – Middle East & Africa (MEA) Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026

This chapter provides information about how the Humanized Liver Mice Model market will grow in the major countries in the MEA region, such as GCC Countries, South Africa and the rest of MEA, during the period 2013-2026.

Chapter 9 – Competition Landscape and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Humanized Liver Mice Model market along with detailed information about each company, including company overview, revenue shares, strategic overview and recent company developments. Market players featured in this report include Yecuris Corporation, PhoenixBio Group, Beijing Vitalstar Biotechnology Co. Ltd., Hera BioLabs, Taconic Biosciences, Inc., University of Massachusetts Medical School, Oncodesign, University of Nebraska Medical Center and Jackson Laboratory.

Chapter 10 – Global Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026, By Model

Based on the Model, the Humanized Liver Mice Model market is segmented into uPA-SCID Mice, FRG KO Mice, TK-NOG Mice and Other Models. In this chapter, readers can find information about the key trends and developments in the Humanized Liver Mice Model market and market attractive analysis based on the model type.

Chapter 11 – Global Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026, By Application

Based on the application, the Humanized Liver Mice Model market is segmented into pharmacokinetics studies, In-vivo liver toxicity tests, drug metabolism studies and other applications. In this chapter, readers can find information about the key trends and developments in the Humanized Liver Mice Model market and market attractive analysis based on the application.

Chapter 12 – Global Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026, By End User

Based on the end user, the Humanized Liver Mice Model market is segmented into pharmaceutical companies, biotechnology companies, CRO’s and academic & research institutes. In this chapter, readers can find information about the key trends and developments in the Humanized Liver Mice Model market and market attractive analysis based on the end user.

Chapter 13 – Global Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026, By Region

This chapter explains how the Humanized Liver Mice Model market will grow across various geographic regions, which include North America, Latin America, Europe, Asia-Pacific (APAC) and the Middle East & Africa (MEA).

Chapter 14 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 15 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information and quantitative information about the Humanized Liver Mice Model market.

レポート目次

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Inclusion and Exclusion

3. Humanized Liver Mice Model Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. Market Background
4.1. Market Evolution
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Trends

5. Global Economic Outlook
5.1. Global Pharmaceutical Industry Outlook

6. Key Inclusions
6.1. Epidemiology- Incidence of Liver Cancer, By Region
6.2. Epidemiology- Incidence of Hepatitis C Virus (HCV) Infection, By Region
6.3. Humanized Liver Mice Model – Liver Diseases Clinical Trials Analysis
6.4. Humanized Liver Mice Model – Patent Analysis (2012-2018)
6.5. Humanized Liver Mice Model Pricing Analysis, By Region
6.6. Porter’s Analysis

7. North America Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
7.4. Historical Market Value (US$ Mn) Trend Analysis By Model, 2013–2017
7.4.1. uPA-SCID
7.4.2. FRG KO Mice
7.4.3. TK-NOG Mice
7.4.4. Other Models
7.5. Market Value (US$ Mn) Forecast By Model, 2018–2026
7.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
7.6.1. Pharmacokinetics Studies
7.6.2. In-vivo Liver Toxicity Testing
7.6.3. Drug Metabolism Studies
7.6.4. Others
7.7. Market Value (US$ Mn) Forecast By Application, 2018–2026
7.8. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
7.8.1. Pharmaceutical Companies
7.8.2. Biotechnology Companies
7.8.3. Contract Research Organizations (CRO’s)
7.8.4. Academic & Research Institutes
7.9. Market Value (US$ Mn) Forecast By End User, 2018–2026
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Model
7.10.3. By Application
7.10.4. By End User
7.11. Drivers and Restraints – Impact Analysis

8. Latin America Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Value (US$ Mn) Trend Analysis By Model, 2013–2017
8.4.1. uPA-SCID
8.4.2. FRG KO Mice
8.4.3. TK-NOG Mice
8.4.4. Other Models
8.5. Market Value (US$ Mn) Forecast By Model, 2018–2026
8.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
8.6.1. Pharmacokinetics Studies
8.6.2. In-vivo Liver Toxicity Testing
8.6.3. Drug Metabolism Studies
8.6.4. Others
8.7. Market Value (US$ Mn) Forecast By Application, 2018–2026
8.8. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
8.8.1. Pharmaceutical Companies
8.8.2. Biotechnology Companies
8.8.3. Contract Research Organizations (CRO’s)
8.8.4. Academic & Research Institutes
8.9. Market Value (US$ Mn) Forecast By End User, 2018–2026
8.10. Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Model
8.10.3. By Application
8.10.4. By End User
8.11. Drivers and Restraints – Impact Analysis

9. Europe Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
9.2.1. U.K.
9.2.2. Germany
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
9.4. Historical Market Value (US$ Mn) Trend Analysis By Model, 2013–2017
9.4.1. uPA-SCID
9.4.2. FRG KO Mice
9.4.3. TK-NOG Mice
9.4.4. Other Models
9.5. Market Value (US$ Mn) Forecast By Model, 2018–2026
9.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
9.6.1. Pharmacokinetics Studies
9.6.2. In-vivo Liver Toxicity Testing
9.6.3. Drug Metabolism Studies
9.6.4. Others
9.7. Market Value (US$ Mn) Forecast By Application, 2018–2026
9.8. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
9.8.1. Pharmaceutical Companies
9.8.2. Biotechnology Companies
9.8.3. Contract Research Organizations (CRO’s)
9.8.4. Academic & Research Institutes
9.9. Market Value (US$ Mn) Forecast By End User, 2018–2026
9.10. Market Attractiveness Analysis
9.10.1. By Country
9.10.2. By Model
9.10.3. By Application
9.10.4. By End User
9.11. Drivers and Restraints – Impact Analysis

10. Asia Pacific Excluding China Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026
10.1. Introduction
10.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
10.2.1. Japan
10.2.2. India
10.2.3. Australia and New Zealand
10.2.4. South Korea
10.2.5. ASEAN
10.2.6. Rest of Asia Pacific
10.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
10.4. Historical Market Value (US$ Mn) Trend Analysis By Model, 2013–2017
10.4.1. uPA-SCID
10.4.2. FRG KO Mice
10.4.3. TK-NOG Mice
10.4.4. Other Models
10.5. Market Value (US$ Mn) Forecast By Model, 2018–2026
10.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
10.6.1. Pharmacokinetics Studies
10.6.2. In-vivo Liver Toxicity Testing
10.6.3. Drug Metabolism Studies
10.6.4. Others
10.7. Market Value (US$ Mn) Forecast By Application, 2018–2026
10.8. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
10.8.1. Pharmaceutical Companies
10.8.2. Biotechnology Companies
10.8.3. Contract Research Organizations (CRO’s)
10.8.4. Academic & Research Institutes
10.9. Market Value (US$ Mn) Forecast By End User, 2018–2026
10.10. Market Attractiveness Analysis
10.10.1. By Country
10.10.2. By Model
10.10.3. By Application
10.10.4. By End User
10.11. Drivers and Restraints – Impact Analysis

11. China Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026
11.1. Introduction
11.2. Historical Market Value (US$ Mn) Trend Analysis By Model, 2013–2017
11.2.1. uPA-SCID
11.2.2. FRG KO Mice
11.2.3. TK-NOG Mice
11.2.4. Other Models
11.3. Market Value (US$ Mn) Forecast By Model, 2018–2026
11.4. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
11.4.1. Pharmacokinetics Studies
11.4.2. In-vivo Liver Toxicity Testing
11.4.3. Drug Metabolism Studies
11.4.4. Others
11.5. Market Value (US$ Mn) Forecast By Application, 2018–2026
11.6. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
11.6.1. Pharmaceutical Companies
11.6.2. Biotechnology Companies
11.6.3. Contract Research Organizations (CRO’s)
11.6.4. Academic & Research Institutes
11.7. Market Value (US$ Mn) Forecast By End User, 2018–2026
11.8. Market Attractiveness Analysis
11.8.1. By Model
11.8.2. By Application
11.8.3. By End User
11.10. Drivers and Restraints – Impact Analysis

12. Middle East & Africa Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026
12.1. Introduction
12.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013–2017
12.2.1. GCC Countries
12.2.2. South Africa
12.2.3. Rest of MEA
12.3. Market Value (US$ Mn) Forecast By Country, 2018–2026
12.4. Historical Market Value (US$ Mn) Trend Analysis By Model, 2013–2017
12.4.1. uPA-SCID
12.4.2. FRG KO Mice
12.4.3. TK-NOG Mice
12.4.4. Other Models
12.5. Market Value (US$ Mn) Forecast By Model, 2018–2026
12.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
12.6.1. Pharmacokinetics Studies
12.6.2. In-vivo Liver Toxicity Testing
12.6.3. Drug Metabolism Studies
12.6.4. Others
12.7. Market Value (US$ Mn) Forecast By Application, 2018–2026
12.8. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
12.8.1. Pharmaceutical Companies
12.8.2. Biotechnology Companies
12.8.3. Contract Research Organizations (CRO’s)
12.8.4. Academic & Research Institutes
12.9. Market Value (US$ Mn) Forecast By End User, 2018–2026
12.10. Market Attractiveness Analysis
12.10.1. By Country
12.10.2. By Model
12.10.3. By Application
12.10.4. By End User
12.11. Drivers and Restraints – Impact Analysis

13. Forecast Factors: Relevance and Impact

14. Forecast Assumptions

15. Market Structure Analysis
15.1. Market Structure by Tier of Companies

16. Competition Analysis
16.1. Company Share
16.2. Competition Dashboard
16.3. Key Developments
16.4. Company Product Matrix
16.5. Company Deep Dive
16.5.1. Hera BioLabs
16.5.1.1. Overview
16.5.1.2. Analyst Commentary
16.5.2. Taconic Biosciences, Inc.
16.5.3. Beijing Vitalstar Biotechnology Co., Ltd.
16.5.4. Yecuris Corporation
16.5.5. PhoenixBio Group
16.5.6. In-Vivo Science Inc.
16.5.7. The Jackson Laboratory
16.5.8. University of Massachusetts Medical School(Mueller Lab)
16.5.9. Oncodesign
16.5.10. University of Nebraska Medical Center

17. Global Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026, By Region
17.1. Introduction/Key Findings
17.2. Historical Market Value (US$ Mn) Trend Analysis By Region, 2013–2017
17.3. Market Value (US$ Mn) Forecast By Region, 2018–2026
17.3.1. North America
17.3.2. Latin America
17.3.3. Europe
17.3.4. Asia Pacific Excluding China
17.3.5. China
17.3.6. Middle East & Africa
17.4. Market Attractiveness Analysis By Region

18. Global Humanized Liver Mice Analysis 2013–2017 and Forecast 2018–2026, By Model
18.1. Introduction/Key Findings
18.2. Historical Market Value (US$ Mn) Trend Analysis By Model, 2013–2017
18.2.1. uPA-SCID
18.2.2. FRG KO Mice
18.2.3. TK-NOG Mice
18.2.4. Other Models
18.3. Market Value (US$ Mn) Forecast By Model, 2018–2026
18.4. Market Attractiveness Analysis By Model

19. Global Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026, By Application
19.1. Introduction/Key Findings
19.2. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
19.2.1. Pharmacokinetics Studies
19.2.2. In-vivo Liver Toxicity Testing
19.2.3. Drug Metabolism Studies
19.2.4. Others
19.3. Market Value (US$ Mn) Forecast By Application, 2018–2026
19.4. Market Attractiveness Analysis By Application

20. Global Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026, By End User
20.1. Introduction/Key Findings
20.2. Historical Market Value (US$ Mn) Trend Analysis By End User, 2013–2017
20.2.1. Pharmaceutical Companies
20.2.2. Biotechnology Companies
20.2.3. Contract Research Organizations (CRO’s)
20.2.4. Academic & Research Institutes
20.3. Market Value (US$ Mn) Forecast By End User, 2018–2026
20.4. Market Attractiveness Analysis By End User

21. Global Humanized Liver Mice Model Market Analysis 2013–2017 and Forecast 2018–2026
21.1. Market Value Share Analysis By All Segment
21.2. Y-o-Y Growth Analysis By All Segment
21.3. Absolute $ Opportunity

22. Research Methodology

List of Table

Table 1: North America Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 2: North America Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Model
Table 3: North America Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 4: North America Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 5: Latin America Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 6: Latin America Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Model
Table 7: Latin America Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 8: Latin America Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 9: Europe Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 10: Europe Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Model
Table 11: Europe Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 12: Europe Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 13: APEC Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 14: APEC Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Model
Table 15: APEC Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 16: APEC Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 17: China Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Model
Table 18: China Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 19: China Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 20: MEA Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 21: MEA Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Model
Table 22: MEA Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 23: MEA Humanized Liver Mice Model Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 24: Global Humanized Liver Mice Model Market size (US$ Mn) Analysis 2013–2016 and Forecast 2017–2026, By Region
Table 25: Global Humanized Liver Mice Model Market size (US$ Mn) Analysis 2013–2016 and Forecast 2017–2026, By Model
Table 26: Global Humanized Liver Mice Model Market size (US$ Mn) Analysis 2013–2016 and Forecast 2017–2026, By Application
Table 27: Global Humanized Liver Mice Model Market size (US$ Mn) Analysis 2013–2016 and Forecast 2017–2026, By End User


• 英文レポート名:Global Market Study on Humanized Liver Mice Model: Application in New Drug Development for Liver Cancer to Support Growing Demand for In-vivo Toxicity Testing
• 日本語訳:肝臓ヒト化マウスモデルの世界市場
• レポートコード:C-PMR-JN046お問い合わせ(見積依頼・ご注文・質問)